Brainstorm Cell Therapeutics (BCLI) 10-Q2024 Q1 Quarterly report

Filed: 14 May 24, 5:00pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abuse, adequacy, allege, Andrev, assert, attention, Bob, breach, breached, brought, Burlington, CEO, conclusion, Counsel, Dagher, deadline, Dec, disgorgement, disproportionate, diversion, duty, embark, entry, faith, fiduciary, formalize, Forum, found, Hamby, hearing, Holtzman, hub, linked, Main, matter, member, mismanagement, multimodal, negotiating, Neuro, noncompliance, notification, online, organization, Orlando, paper, Plaintiff, prudent, satisfy, SPA, stayed, suspension, Switzerland, thehe, top, unjust, unsuccessful, Variable, waste, Zurich

Removed: accelerate, accessed, accompanied, account, accredited, accurately, add, affecting, Alzheimer, AMG, anticipated, authority, aware, bank, banking, Beach, bearing, biorepository, Biotech, body, broadly, build, capitalize, Clearwater, compliant, confounding, contagion, Corporation, credit, customer, database, Deposit, difficulty, direct, donated, Dorn, earned, economic, economy, enter, equal, evolving, exempt, expeditiously, expertise, exposed, exposure, Federal, finalize, finance, gave, governmental, Haggai, Harvard, Healey, Hilton, hire, hoc, Ichilov, identify, illustrating, impaired, impairment, inability, independently, industry, Innovation, inside, insolvent, instability, introduced, investing, involving, issuer, jointly, Julieanne, Kaspi, leased, MD, minimizing, Monday, nature, operation, Package, partnered, party, pattern, pipeline, plateau, plummet, posed, power, PR, Professor, progressive, projected, receiver, receivership, regional, remove, representing, requested, resale, revealed, robust, running, Sean, sector, selection, semiautomatic, sharing, Showcase, Signature, Silicon, Silvergate, Square, suggesting, summit, supporting, talk, targeted, threatened, transactional, true, twelve, utilize, Valley, vitro, working

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BCLI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the accompanying Quarterly Report on Form 10-Q of Brainstorm Cell Therapeutics Inc. (the “Company”) for the period ended March 31, 2024, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) such Quarterly Report on Form 10-Q for the period ended March 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2024 fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 14, 2024		/s/ Chaim Lebovits
	Name:	Chaim Lebovits
	Title:	Chief Executive Officer
		(Principal Executive Officer)